查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1514975

磺胺市场，按给药途径、应用、最终用户、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Sulphonamides Market, By Route of Administration, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 263 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2023年磺胺类药物市场规模为1.294亿美元，2024年至2032年复合年增长率为4.50%。

磺胺类药物市场-市场动态

感染、慢性病的盛行率不断上升以及对组合疗法的高需求预计将推动市场需求

随着传染病持续对全球健康构成重大挑战，对磺胺类药物等有效抗生素的需求正在大幅增加。泌尿道感染、呼吸道感染和性传染病等细菌感染的增加推动了对包括磺胺类药物在内的抗生素的需求。磺胺类药物也用于治疗慢性疾病，例如类风湿性关节炎（例如柳氮磺胺吡啶）和发炎性肠道疾病。这些疾病的流行推动了对含有磺胺成分的药物的持续需求。

磺胺类药物通常与其他抗生素（如甲氧芐啶，例如复方新诺明）合併使用，以增强疗效并对抗抗药性。此类联合疗法的开发和使用有助于增加临床实践中对磺胺类药物的需求。与新型抗生素相比，磺胺类药物更便宜。这种成本效益在资源有限的医疗系统中尤其重要，这些抗生素仍可提供有效的治疗选择。预计这些因素将促进市场成长。

磺胺类药物市场 - 主要见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032 年）每年将以 4.50% 左右的复合年增长率成长

根据给药途径细分，由于最近的 COVID-19 危机和治疗，预计口服细分市场将在 2023 年显示最大的市场份额。

根据应用细分，泌尿道感染 (UTI) 领域是 2023 年的主要应用，因为细菌感染的增加也会导致死亡率。

根据最终用户细分，由于泌尿、糖尿病和其他慢性疾病的治疗有很高的需求，医院细分市场将在 2023 年成为领先的最终用户。

按地区划分，由于慢性病盛行率较高，北美将成为 2023 年的主要收入来源。

磺胺类药物市场-細項分析：

全球磺胺类药物市场根据给药途径、应用、最终用户和地区进行细分。

根据给药途径，市场分为三类：口服、外用和其他。口腔细分市场占据主导地位。对抗生素和传染病治疗的高需求正在补充市场的成长。

根据应用，市场分为五类：皮肤感染、泌尿道感染（UTI）、呼吸道感染（RTI）、胃肠道（GIT）等。基于 PCR 的方法细分市场占据主导地位。泌尿相关疾病的增加和尿路感染的新研究正在推动细分市场的需求。

根据最终用户，市场分为三类：医院、诊所和其他。医院领域在市场中占据主导地位，预计在预测期内将保持其高度主导地位。皮肤和肾臟传播疾病的技术和治疗的进步主要推动了市场的成长。

磺胺类药物市场 - 地理洞察

在全球范围内，磺胺类药物市场广泛分布于北美、拉丁美洲、欧洲、亚太地区、中东和非洲地区。医疗体系健全的已开发地区，如北美、西欧以及日本、澳洲等亚太地区部分地区，磺胺类药物的消费量往往较高。这是由于更容易获得医疗保健设施。拉丁美洲、东欧、亚太地区（例如印度、中国）和非洲国家正在经历医疗保健支出的增加和医疗保健基础设施的改善。

磺胺类药物市场-竞争格局：

磺胺类药物市场竞争中等。公司根据当地市场条件、监管环境和医疗保健系统调整策略。老牌企业通常拥有全球业务，分销网络遍布多个国家。製造工艺和技术的进步在竞争定位中发挥重要作用。采用和整合新技术进行生产或配方增强的公司可以提高效率和产品品质。此外，竞争公司在研发方面投入巨资，以开发新配方、提高疗效并减少磺胺类药物的副作用。这项持续的研究推动了市场的创新和差异化。

最近的发展：

2022年8月，法雷奥製药公司与加拿大诺华製药公司就SIMBRINZA的商业化达成了供应和商业化协议。

2022年7月，Azurity Pharmaceuticals Inc.获得美国FDA对ZONISADE的认可。

目录

第 1 章：磺胺类药物市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 依给药途径分類的磺胺类市场片段
    • 磺胺类药物市场片段（依应用）
    • 最终用户的磺胺市场片段
    • 按国家/地区分類的磺胺类市场片段
    • 按地区分類的磺胺类市场片段
  • 竞争洞察

第 3 章：磺胺类药物主要市场趋势

  • 磺胺类药物市场驱动因素
    • 市场驱动因素的影响分析
  • 磺胺类药物市场限制
    • 市场限制影响分析
  • 磺胺类药物市场机会
  • 磺胺类药物市场未来趋势

第 4 章：磺胺类药物产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：磺胺类市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：磺胺类药物市场格局

  • 2024 年磺胺类药物市场份额分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：磺胺类药物市场 - 按给药途径

  • 概述
    • 按给药途径分類的细分市场份额分析
    • 口服
    • 专题
    • 其他的

第 8 章：磺胺类药物市场 - 按应用

  • 概述
    • 按应用分類的细分市场占有率分析
    • 皮肤感染
    • 泌尿道感染（UTI）
    • 呼吸道感染 (RTI)
    • 胃肠道 (GIT)
    • 其他的

第 9 章：磺胺类市场 - 按最终用户

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 医院
    • 诊所
    • 其他的

第 10 章：磺胺类药物市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美磺胺类主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模与预测（按管理途径）
    • 北美市场规模和预测（按应用）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲磺胺类主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模与预测（按管理途径）
    • 欧洲市场规模和预测（按应用）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区磺胺类主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（依管理途径）
    • 亚太地区市场规模与预测（按应用）
    • 亚太地区市场规模和预测（按最终用户）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲磺胺类主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按管理途径）
    • 拉丁美洲市场规模与预测（按应用）
    • 拉丁美洲市场规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲磺胺类主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按管理途径）
    • 中东和非洲市场规模及预测（按应用）
    • 中东和非洲市场规模和预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 11 章：主要供应商分析 - 磺胺类药物产业

  • 竞争仪表板
  • 公司简介
    • Pfizer Inc.
    • GlaxoSmithKline plc
    • Novartis AG
    • Sanofi SA
    • F. Hoffmann-La Roche Ltd
    • Merck & Co., Inc.
    • Bayer AG
    • Johnson & Johnson
    • Abbott Laboratories
    • AstraZeneca PLC
    • Teva Pharmaceutical Industries Ltd.
    • Bristol-Myers Squibb Company
    • Valeo Pharma Inc.
    • Eli Lilly and Company
    • Boehringer Ingelheim International GmbH
    • Mylan NV
    • Others

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV3081

REPORT HIGHLIGHT

Sulphonamides Market size was valued at USD 129.40 Million in 2023, expanding at a CAGR of 4.50% from 2024 to 2032.

Sulphonamides, also known as sulfonamides, are a class of synthetic antimicrobial agents that work by inhibiting bacterial growth. Sulphonamides is used to treat a range of infections, including urinary tract infections, respiratory tract infections, bacterial meningitis, and some sexually transmitted infections. They are also sometimes used in combination with other antibiotics for synergistic effects.

Sulphonamides Market- Market Dynamics

Growing prevalence of infection, chronic diseases and high demand for combinational therapies are expected to propel market demand

As infectious diseases continue to pose significant global health challenges, the demand for effective antibiotics like sulphonamides is rising significantly. The rise in bacterial infections such as urinary tract infections, respiratory infections, and sexually transmitted diseases drives the need for antibiotics, including sulphonamides. Sulphonamides are also used in the treatment of chronic conditions such as rheumatoid arthritis (e.g., sulfasalazine) and inflammatory bowel disease. The prevalence of these conditions drives ongoing demand for medications containing sulphonamide components.

Sulphonamides are often used in combination with other antibiotics like trimethoprim e.g., co-trimoxazole to enhance efficacy and combat resistance. The development and use of such combination therapies contribute to the demand for sulphonamides in clinical practice. Sulphonamides are more affordable compared to newer antibiotics. This cost-effectiveness is particularly important in healthcare systems with limited resources, where these antibiotics can still provide effective treatment options. These factors are expected to bolster market growth.

Sulphonamides Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 4.50% over the forecast period (2024-2032)

Based on Route of Administration segmentation, the oral segment was predicted to show maximum market share in the year 2023, owing to the recent COVID-19 crisis & cure.

Based on Application segmentation, the urinary tract infection (UTI) segment was the leading Application in 2023, owing to rising bacterial infection that causes mortality also.

Based on End User segmentation, the hospital segment was the leading End User in 2023, owing to the high need for treatment of urinary, diabetic, and other chronic disorders.

On the basis of region, North America was the leading revenue generator in 2023, owing to high prevalence of chronic diseases.

Sulphonamides Market- Segmentation Analysis:

The Global Sulphonamides Market is segmented on the basis of Route of Administration, Application, End User, and Region.

The market is divided into three categories based on the Route of Administration: oral, topical, and others. The oral segment dominates the market. The high demand for antibiotics and infectious disease treatment is supplementing the market growth.

The market is divided into five categories based on the Application: skin infection, urinary tract infection (UTI), respiratory tract infection (RTI), gastrointestinal tract (GIT), and others. The PCR-based method segment dominates the market. Rising urinary-related diseases and new research in UTIs is contributing to segment demand.

The market is divided into three categories based on End Users: hospitals, clinics, and others. The hospital segment dominates the market and is expected to maintain its high dominance during the forecast period. The advancement in technologies and treatment of skin, and kidney transmitted disorders are mainly boosting the market growth.

Sulphonamides Market- Geographical Insights

Worldwide, the Sulphonamides market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Developed regions with robust healthcare systems, such as North America, Western Europe, and parts of Asia-Pacific including Japan, Australia, etc. often have higher consumption of sulphonamides. This is due to better access to healthcare facilities. Countries in Latin America, Eastern Europe, Asia-Pacific (e.g., India, China), and Africa are experiencing increasing healthcare expenditure and improving healthcare infrastructure.

Sulphonamides Market- Competitive Landscape:

The Sulphonamides market is moderately competitive. Companies adapt their strategies to local market conditions, regulatory environments, and healthcare systems. Established players often have a global presence with distribution networks spanning multiple countries. Advances in manufacturing processes and technologies play a significant role in competitive positioning. Companies that adopt and integrate new technologies for production or formulation enhancement can improve efficiency and product quality. Further, competing companies invest heavily in R&D to develop new formulations, improve efficacy, and reduce the side effects of sulphonamide drugs. This ongoing research drives innovation and differentiation in the market.

Recent Developments:

In August 2022, Valeo Pharma Inc. formed a supply and commercialization agreement with Novartis Pharmaceuticals in Canada for the commercialization of SIMBRINZA.

In July 2022, Azurity Pharmaceuticals Inc. established endorsement from the US FDA for ZONISADE.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL SULPHONAMIDES MARKET KEY PLAYERS

  • Pfizer Inc.
  • GlaxoSmithKline plc
  • Novartis AG
  • Sanofi S.A.
  • F. Hoffmann-La Roche Ltd
  • Merck & Co., Inc.
  • Bayer AG
  • Johnson & Johnson
  • Abbott Laboratories
  • AstraZeneca PLC
  • Teva Pharmaceutical Industries Ltd.
  • Bristol-Myers Squibb Company
  • Valeo Pharma Inc.
  • Eli Lilly and Company
  • Boehringer Ingelheim International GmbH
  • Mylan N.V.
  • Others

GLOBAL SULPHONAMIDES MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2019-2032

  • Oral
  • Topical
  • Others

GLOBAL SULPHONAMIDES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019-2032

  • Skin infection
  • Urinary Tract Infection (UTI)
  • Respiratory Tract Infection (RTI)
  • Gastro-Intestinal Tract (GIT)
  • Others

GLOBAL SULPHONAMIDES MARKET, BY END USER- MARKET ANALYSIS, 2019-2032

  • Hospitals
  • Clinics
  • Others

GLOBAL SULPHONAMIDES MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Sulphonamides Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Sulphonamides Market Snippet by Route of Administration
    • 2.1.2. Sulphonamides Market Snippet by Application
    • 2.1.3. Sulphonamides Market Snippet by End User
    • 2.1.4. Sulphonamides Market Snippet by Country
    • 2.1.5. Sulphonamides Market Snippet by Region
  • 2.2. Competitive Insights

3. Sulphonamides Key Market Trends

  • 3.1. Sulphonamides Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Sulphonamides Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Sulphonamides Market Opportunities
  • 3.4. Sulphonamides Market Future Trends

4. Sulphonamides Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Sulphonamides Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Sulphonamides Market Landscape

  • 6.1. Sulphonamides Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Sulphonamides Market - By Route of Administration

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Route of Administration, 2024 & 2032 (%)
    • 7.1.2. Oral
    • 7.1.3. Topical
    • 7.1.4. Others

8. Sulphonamides Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 8.1.2. Skin infection
    • 8.1.3. Urinary Tract Infection (UTI)
    • 8.1.4. Respiratory Tract Infection (RTI)
    • 8.1.5. Gastro-Intestinal Tract (GIT)
    • 8.1.6. Others

9. Sulphonamides Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Clinics
    • 9.1.4. Others

10. Sulphonamides Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Sulphonamides Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Sulphonamides Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Sulphonamides Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Sulphonamides Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Sulphonamides Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Sulphonamides Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Pfizer Inc.
    • 11.2.2. GlaxoSmithKline plc
    • 11.2.3. Novartis AG
    • 11.2.4. Sanofi S.A.
    • 11.2.5. F. Hoffmann-La Roche Ltd
    • 11.2.6. Merck & Co., Inc.
    • 11.2.7. Bayer AG
    • 11.2.8. Johnson & Johnson
    • 11.2.9. Abbott Laboratories
    • 11.2.10. AstraZeneca PLC
    • 11.2.11. Teva Pharmaceutical Industries Ltd.
    • 11.2.12. Bristol-Myers Squibb Company
    • 11.2.13. Valeo Pharma Inc.
    • 11.2.14. Eli Lilly and Company
    • 11.2.15. Boehringer Ingelheim International GmbH
    • 11.2.16. Mylan N.V.
    • 11.2.17. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Sulphonamides Market: Route of Administration Snapshot (2024)
  • TABLE Segment Dashboard; Definition and Scope, by Route of Administration
  • TABLE Global Sulphonamides Market, by Route of Administration 2019-2032 (USD Million)
  • TABLE Sulphonamides Market: Application Snapshot (2024)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Sulphonamides Market, by Application 2019-2032 (USD Million)
  • TABLE Sulphonamides Market: End User Snapshot (2024)
  • TABLE Segment Dashboard; Definition and Scope, by End User
  • TABLE Global Sulphonamides Market, by End User 2019-2032 (USD Million)
  • TABLE Sulphonamides Market: Regional snapshot (2024)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Sulphonamides Market, by Region 2019-2032 (USD Million)
  • TABLE North America Sulphonamides Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Sulphonamides Market, by Route of Administration, 2019-2032 (USD Million)
  • TABLE North America Sulphonamides Market, by Application, 2019-2032 (USD Million)
  • TABLE North America Sulphonamides Market, by End User, 2019-2032 (USD Million)
  • TABLE Europe Sulphonamides Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Sulphonamides Market, by Route of Administration, 2019-2032 (USD Million)
  • TABLE Europe Sulphonamides Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Sulphonamides Market, by End User, 2019-2032 (USD Million)
  • TABLE Asia Pacific Sulphonamides Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Sulphonamides Market, by Route of Administration, 2019-2032 (USD Million)
  • TABLE Asia Pacific Sulphonamides Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Sulphonamides Market, by End User, 2019-2032 (USD Million)
  • TABLE Latin America Sulphonamides Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Sulphonamides Market, by Route of Administration, 2019-2032 (USD Million)
  • TABLE Latin America Sulphonamides Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Sulphonamides Market, by End User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Sulphonamides Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Sulphonamides Market, by Route of Administration, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Sulphonamides Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Sulphonamides Market, by End User, 2019-2032 (USD Million)

List of Figures

  • FIGURE Sulphonamides Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2024
  • FIGURE Route of Administration segment market share analysis, 2024 & 2032
  • FIGURE Route of Administration segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Application segment market share analysis, 2024 & 2032
  • FIGURE Application segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE End User segment market share analysis, 2024 & 2032
  • FIGURE End User segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Regional segment market share analysis, 2024 & 2032
  • FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE North America Sulphonamides Market share and leading players, 2024
  • FIGURE Europe Sulphonamides Market share and leading players, 2024
  • FIGURE Asia Pacific Sulphonamides Market share and leading players, 2024
  • FIGURE Latin America Sulphonamides Market share and leading players, 2024
  • FIGURE Middle East and Africa Sulphonamides Market share and leading players, 2024
  • FIGURE North America market share analysis by country, 2024
  • FIGURE U.S. Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Canada Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Europe Sulphonamides Market share analysis by country, 2024
  • FIGURE Germany Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Spain Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Italy Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE France Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE UK Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Russia Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Netherlands Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Sweden Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Poland Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of the Europe Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Asia Pacific Sulphonamides Market share analysis by country, 2024
  • FIGURE India Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE China Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Japan Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE South Korea Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Australia Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Thailand Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indonesia Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Philipines Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of APAC Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Sulphonamides Market share analysis by country, 2024
  • FIGURE Brazil Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mexico Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Argentina Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Colombia Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of LATAM Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Sulphonamides Market share analysis by country, 2024
  • FIGURE Saudi Arabia Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE United Arab Emirates Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Israel Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Turkey Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Algeria Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Egypt Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of MEA Sulphonamides Market size, forecast and trend analysis, 2019 to 2032 (USD Million)